Rethinking Mild Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: Dead End or Missed Opportunity? An Expert Viewpoint
Journal of Clinical Medicine · 2026-11-06 · 15 (21) · 8676
DOI: 10.3390/jcm15218676 ↗Abstract
Out-of-hospital cardiac arrest remains associated with high mortality and neurological disability. Mild therapeutic hypothermia has been questioned after large trials failed to demonstrate superiority over controlled normothermia with fever prevention. In this expert viewpoint, we argue that these neutral findings should not be interpreted as proof of biological futility in every patient and setting. The clinical effect of hypothermia may depend on patient phenotype, timing of initiation, cooling technique, temperature-control quality, and integration with contemporary post-resuscitation care. This may be particularly important in patients undergoing percutaneous coronary intervention, in whom hypothermia can impair the pharmacokinetics and antiplatelet effects of oral P2Y12 inhibitors. Current evidence does not support routine hypothermia in all comatose survivors. However, uncertainty remains regarding its value in selected patients. Patients with an intermediate degree of ischemic brain injury may represent a plausible target for neuroprotection, but this remains an unproven hypothesis. Future trials should investigate whether injury severity modifies the effects of early, precisely delivered hypothermia, using standardized protocols, active normothermia as the comparator, and prespecified antithrombotic and post-resuscitation strategies.
EUVIMED